• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌醇磷酸酶SHIP抑制B细胞中的Akt/PKB激活。

The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells.

作者信息

Aman M J, Lamkin T D, Okada H, Kurosaki T, Ravichandran K S

机构信息

Beirne Carter Center for Immunology Research and the Department of Microbiology, University of Virginia, Charlottesville, Virginia 22908, USA.

出版信息

J Biol Chem. 1998 Dec 18;273(51):33922-8. doi: 10.1074/jbc.273.51.33922.

DOI:10.1074/jbc.273.51.33922
PMID:9852043
Abstract

The serine-threonine kinase Akt/PKB is activated downstream of phosphatidylinositol 3-kinase in response to several growth factor stimuli and has been implicated in the promotion of cell survival. Although both phosphatidylinositol 3,4,5-trisphosphate (PIP3) and phosphatidylinositol 3,4-bisphosphate (PI 3,4-P2) have been implicated in the regulation of Akt activity in vitro, the relative roles of these two phospholipids in vivo are not well understood. Co-ligation of the B cell receptor (BCR) and the inhibitory FcgammaRIIB1 on B cells results in the recruitment of the 5'-inositol phosphatase SHIP to the signaling complex. Since SHIP is known to cleave PIP3 to generate PI 3,4-P2 both in vivo and in vitro, and Akt activity has been reported to be regulated by either PIP3 or PI 3,4-P2, we hypothesized that recruitment of SHIP through FcgammaRIIB1 co-cross-linking to the BCR in B cells might regulate Akt activity. The nature of this regulation, positive or negative, might also reveal the relative contribution of PIP3 and PI 3,4-P2 to Akt activation in vivo. Here we report that Akt is activated by stimulation through the BCR in a phosphatidylinositol 3-kinase-dependent manner and that this activation is inhibited by co-cross-linking of the BCR to FcgammaRIIB1. Using mutants of FcgammaRIIB1 and SHIP-deficient B cells, we demonstrate that inhibition of Akt activity is mediated by the immune cell tyrosine-based inhibitory motif within FcgammaRIIB1 as well as SHIP. The SHIP-dependent inhibition of Akt activation also suggests that PIP3 plays a greater role in Akt activation than PI 3,4-P2 in vivo.

摘要

丝氨酸 - 苏氨酸激酶Akt/PKB在磷脂酰肌醇3激酶下游被激活,以响应多种生长因子刺激,并与促进细胞存活有关。尽管磷脂酰肌醇3,4,5 - 三磷酸(PIP3)和磷脂酰肌醇3,4 - 二磷酸(PI 3,4 - P2)在体外均与Akt活性的调节有关,但这两种磷脂在体内的相对作用尚不清楚。B细胞上B细胞受体(BCR)与抑制性FcγRIIB1的共连接导致5'-肌醇磷酸酶SHIP募集到信号复合物中。由于已知SHIP在体内和体外均可将PIP3切割生成PI 3,4 - P2,并且据报道Akt活性受PIP3或PI 3,4 - P2调节,我们推测通过FcγRIIB1共交联将SHIP募集到B细胞中的BCR可能调节Akt活性。这种调节的性质,是正向还是负向,也可能揭示PIP3和PI 3,4 - P2在体内对Akt激活的相对贡献。在此我们报道,Akt通过BCR刺激以磷脂酰肌醇3激酶依赖性方式被激活,并且这种激活被BCR与FcγRIIB1的共交联所抑制。使用FcγRIIB1突变体和SHIP缺陷型B细胞,我们证明Akt活性的抑制是由FcγRIIB1内基于免疫细胞酪氨酸的抑制基序以及SHIP介导的。SHIP依赖性对Akt激活的抑制也表明,在体内PIP3在Akt激活中比PI 3,4 - P2发挥更大作用。

相似文献

1
The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells.肌醇磷酸酶SHIP抑制B细胞中的Akt/PKB激活。
J Biol Chem. 1998 Dec 18;273(51):33922-8. doi: 10.1074/jbc.273.51.33922.
2
The SH2 domain-containing inositol 5'-phosphatase (SHIP) recruits the p85 subunit of phosphoinositide 3-kinase during FcgammaRIIb1-mediated inhibition of B cell receptor signaling.含SH2结构域的肌醇5'-磷酸酶(SHIP)在FcγRIIb1介导的B细胞受体信号传导抑制过程中募集磷脂酰肌醇3激酶的p85亚基。
J Biol Chem. 1999 Mar 12;274(11):7489-94. doi: 10.1074/jbc.274.11.7489.
3
Heterologous regulation of chemokine receptor signaling by the lipid phosphatase SHIP in lymphocytes.脂质磷酸酶SHIP对淋巴细胞趋化因子受体信号传导的异源调节
Cell Signal. 2005 Oct;17(10):1194-202. doi: 10.1016/j.cellsig.2004.12.009.
4
Partially distinct molecular mechanisms mediate inhibitory FcgammaRIIB signaling in resting and activated B cells.部分不同的分子机制介导静息和活化B细胞中抑制性FcγRIIB信号传导。
J Immunol. 2001 Jul 1;167(1):204-11. doi: 10.4049/jimmunol.167.1.204.
5
SHIP inhibits Akt activation in B cells through regulation of Akt membrane localization.SHIP通过调节Akt的膜定位来抑制B细胞中的Akt激活。
Blood. 2000 Aug 15;96(4):1449-56.
6
The dynamics of protein kinase B regulation during B cell antigen receptor engagement.B细胞抗原受体激活过程中蛋白激酶B的调控动态
J Cell Biol. 1999 Jun 28;145(7):1511-20. doi: 10.1083/jcb.145.7.1511.
7
Role of the inositol phosphatase SHIP in B cell receptor-induced Ca2+ oscillatory response.肌醇磷酸酶SHIP在B细胞受体诱导的Ca2+振荡反应中的作用。
J Immunol. 1998 Nov 15;161(10):5129-32.
8
Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.SHIP-1在T淋巴细胞中参与磷脂酰肌醇3,4,5-三磷酸代谢并可调节新型磷酸肌醇3-激酶效应器的证据。
J Immunol. 2002 Nov 15;169(10):5441-50. doi: 10.4049/jimmunol.169.10.5441.
9
The inositol 5'-phosphatase SHIP-1 and the Src kinase Lyn negatively regulate macrophage colony-stimulating factor-induced Akt activity.肌醇5'-磷酸酶SHIP-1和Src激酶Lyn对巨噬细胞集落刺激因子诱导的Akt活性具有负向调节作用。
J Biol Chem. 2003 Oct 3;278(40):38628-36. doi: 10.1074/jbc.M305021200. Epub 2003 Jul 25.
10
p135 src homology 2 domain-containing inositol 5'-phosphatase (SHIPbeta ) isoform can substitute for p145 SHIP in fcgamma RIIB1-mediated inhibitory signaling in B cells.含p135 src同源结构域2的肌醇5'-磷酸酶(SHIPβ)亚型可在B细胞中替代p145 SHIP参与FcγRIIB1介导的抑制性信号传导。
J Biol Chem. 2000 Sep 29;275(39):29960-7. doi: 10.1074/jbc.M003714200.

引用本文的文献

1
SHIP-1 regulates the differentiation and function of Tregs via inhibiting mTORC1 activity.SHIP-1通过抑制mTORC1活性来调节调节性T细胞的分化和功能。
Cell Mol Life Sci. 2024 Dec 21;82(1):10. doi: 10.1007/s00018-024-05470-2.
2
N-WASP-dependent branched actin polymerization attenuates B-cell receptor signaling by increasing the molecular density of receptor clusters.N-WASP 依赖性分支状肌动蛋白聚合通过增加受体簇的分子密度来减弱 B 细胞受体信号。
Elife. 2023 Dec 12;12:RP87833. doi: 10.7554/eLife.87833.
3
/SHIP1: Expression, Regulation and Roles in Alzheimer's Disease Pathophysiology.
/SHIP1:在阿尔茨海默病病理生理学中的表达、调节和作用。
Genes (Basel). 2023 Sep 23;14(10):1845. doi: 10.3390/genes14101845.
4
FCRL1 Regulates B Cell Receptor-Induced ERK Activation through GRB2.FCRL1 通过 GRB2 调节 B 细胞受体诱导的 ERK 激活。
J Immunol. 2021 Dec 1;207(11):2688-2698. doi: 10.4049/jimmunol.2100218. Epub 2021 Oct 25.
5
Beyond the Cell Surface: Targeting Intracellular Negative Regulators to Enhance T cell Anti-Tumor Activity.超越细胞表面:靶向细胞内负调控因子以增强 T 细胞抗肿瘤活性。
Int J Mol Sci. 2019 Nov 20;20(23):5821. doi: 10.3390/ijms20235821.
6
Lyn, Lupus, and (B) Lymphocytes, a Lesson on the Critical Balance of Kinase Signaling in Immunity.琳、狼疮和(B)淋巴细胞,关于免疫中激酶信号关键平衡的一堂课。
Front Immunol. 2018 Mar 1;9:401. doi: 10.3389/fimmu.2018.00401. eCollection 2018.
7
Role of MicroRNA in Proliferation Phase of Wound Healing.微小RNA在伤口愈合增殖期的作用。
Front Genet. 2018 Feb 14;9:38. doi: 10.3389/fgene.2018.00038. eCollection 2018.
8
B Cell Receptor Activation Predominantly Regulates AKT-mTORC1/2 Substrates Functionally Related to RNA Processing.B细胞受体激活主要在功能上调节与RNA加工相关的AKT-mTORC1/2底物。
PLoS One. 2016 Aug 3;11(8):e0160255. doi: 10.1371/journal.pone.0160255. eCollection 2016.
9
Xenotransplantation elicits salient tumorigenicity of adult T-cell leukemia-derived cells via aberrant AKT activation.异种移植通过异常的AKT激活引发成人T细胞白血病衍生细胞的显著致瘤性。
Cancer Sci. 2016 May;107(5):638-43. doi: 10.1111/cas.12921. Epub 2016 Apr 7.
10
Suppression of innate and adaptive B cell activation pathways by antibody coengagement of FcγRIIb and CD19.通过FcγRIIb和CD19的抗体共结合抑制先天性和适应性B细胞激活途径。
MAbs. 2014 Jul-Aug;6(4):991-9. doi: 10.4161/mabs.28841. Epub 2014 Apr 23.